We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI Identifies Hidden Stroke Risk Through At-Home Behavior Patterns

By HospiMedica International staff writers
Posted on 13 Jul 2026

Cerebrovascular disease can lead to serious aftereffects when treatment is delayed, yet early risk is difficult to detect before symptoms appear. More...

Subtle, pre-symptomatic changes in daily living often go unnoticed in clinic-based evaluations. Earlier identification could prompt timely medical assessment and prevention. To help address this challenge, researchers have developed an artificial intelligence (AI) approach that analyzes real-life daily activity and environmental data from older adults to flag digital behavioral markers of cerebrovascular disease risk.

KAIST (Daejeon, South Korea) led the development of an AI framework designed to identify the prodromal phase of cerebrovascular disease and to assess imminent diagnostic risk. The work involved collaboration with Sungkyunkwan University’s School of Electronic and Electrical Engineering and the Department of Neurology at Korea University Anam Hospital. The system focuses on detecting risk trajectories at home, where changes emerge gradually and may precede symptom-driven care.

The study used lifelog data gathered in real residential environments from 1,224 older adults collected by LivOn Care Co., Ltd. Investigators analyzed 13,362 two-week lifelog samples to examine whether small day-to-day variations could reveal early warning signals. The analysis demonstrated the feasibility of pre-symptomatic detection based on routine living patterns rather than event-driven care.

The AI evaluates daily activity, sleep, circadian rhythm, and indoor environmental information, together with age and chronic disease data. It applies explainable AI methods to pinpoint which behavior and environment features underlie its judgments. By tracking longitudinal lifestyle patterns, the framework determines risk stages and highlights when a diagnostic encounter may be approaching.

Distinct behavioral signatures emerged. Older adults in the prodromal phase tended to show frequent continuous activity between 10 p.m. and 2 a.m., indicating irregular rhythms with delayed sleep onset and a blunted distinction between day and night activity. As diagnosis approached, evening (6 p.m. to 10 p.m.) continuous activity decreased while inactive time increased, and low indoor humidity also signaled an imminent diagnostic risk.

When lifelog data within four weeks before diagnosis were labeled as an “imminent diagnostic risk period,” and data from 12 weeks prior as a “non-imminent period,” the AI distinguished between these windows with 96.53% accuracy. The researchers emphasized that the technology does not predict the exact onset of disease or replace clinical diagnosis. They noted it is intended to support prevention and early consultation, and that prospective validation in larger patient groups is needed before clinical use.

The findings were published on June 2 in npj Digital Medicine.

“The key point of this study is not that AI should replace a hospital diagnosis, but that it can first detect risk signals in small lifestyle changes at home and help connect patients to medical care at the right time. We expect this technology to contribute to a shift from a healthcare system that treats disease after it occurs to one that supports prevention and early intervention,” said Lisa Lim, Professor, Department of Civil and Environmental Engineering, KAIST.

Related Links: 
KAIST


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Adhesive
MED 5570U
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image: Visual Abstract (Sinuo Gao, Zhaoqi Zhang, Chao Shi, Cheng Cheng, Xindi Ma, Xinming Zhao, Yunjiang Liu Journal of Nuclear Medicine Oct 2026, 67 (10) 1552-1559; DOI: 10.2967/jnumed.125.271529)

Targeted PET/CT Predicts Early Treatment Response in HER2-Positive Breast Cancer

HER2-positive breast cancer is an aggressive subtype that accounts for a substantial proportion of breast cancer cases. Patients often receive neoadjuvant therapy before surgery to shrink tumors, but assessing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.